Cleared Special

K043546 - DIMENSION RXL MAX WITH STREAMLAB ANALYTICAL WORKCELL AND SAMPLE TRANSFER MODULE
(FDA 510(k) Clearance)

Jan 2005
Decision
26d
Days
Class 1
Risk

K043546 is an FDA 510(k) clearance for the DIMENSION RXL MAX WITH STREAMLAB ANALYTICAL WORKCELL AND SAMPLE TRANSFER MODULE. This device is classified as a Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides (Class I - General Controls, product code CDT).

Submitted by Dade Behring, Inc. (Newark, US). The FDA issued a Cleared decision on January 18, 2005, 26 days after receiving the submission on December 23, 2004.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1705.

Submission Details

510(k) Number K043546 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2004
Decision Date January 18, 2005
Days to Decision 26 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CDT — Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1705

Similar Devices — CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides

All 150
Triglycerides
K150819 · Randox Laboratories Limited · Aug 2015
ADVIA CHEMISTRY TRIGLYCERIDES_2 (TRIG_2) REAGENT
K133067 · Siemens Healthcare Diagnostics, Inc. · Nov 2013
VITROS CHEMISTRY PRODUCTS TRIG SLIDES
K130332 · Ortho-Clinical Diagnostics, Inc. · May 2013
VANTERA CLINICAL ANALYZER
K113830 · Liposcience · Aug 2012
ELITECH CLINICAL SYSTEMS TRIGLYCERIDES SL, ELITECH CLINICAL SYSTEMS CHOLESTEROL SL
K102993 · Seppim S.A.S. · May 2011
OLYMPUS TRIGLYCERIDE TEST SYSTEM
K063804 · Olympus America, Inc. · Mar 2007